We have previously reported that intravenous administration of splenocytes prepared from mice in the early stages of pregnancy promoted embryo implantation in pseudopregnant mice. Since a T-lymphocyte-rich, but not a monocyte-rich preparation from splenocytes enhanced embryo implantation, similar effects of thymocytes from non-pregnant mice on implantation were examined in this study. Thymocytes were prepared from immature 21 day old ICR female mice and the supernatant of a thymocyte suspension (Th-sup) was used as the control. Thymocytes or Th-sup were injected into the caudal vein of recipient mice on pseudopregnancy day 2, and blastocysts were transferred into the endometrial lumen. The implantation rates per recipient were significantly higher in the thymocyte-treated group. ICR mice were then oophorectomized on pseudopregnancy day 3. After 3-day progesterone supplementation, blastocysts were transferred with intravenous injection of thymocytes or Th-sup. Under progesterone supplementation, successful implantations were observed in the thymocyte-treated group, but not in the Th-sup-treated group. Reverse transcriptase-polymerase chain reaction analysis revealed that mRNA expression of leukaemia inhibitory factor in the uterus was induced by thymocyte administration, but not by Th-sup. Thymocytes were divided into two populations, CD4(⍣/-)CD8(-) group and CD4(-)CD8(⍣/-) group, by separation columns. On pseudopregnancy day 2, the separated thymocytes in each group or their supernatant were injected into the endometrial stroma of the recipient mice, and blastocysts were transferred into the endometrial lumen. The administration of CD4(⍣/-) CD8(-) lymphocytes significantly promoted implantation rates, but no effect was observed in the CD4(-) CD8(⍣/-) group. These findings showed that thymocytes, especially CD4-positive lymphocytes, facilitate embryo implantation, probably by regulating endometrial differentiation.
Introduction
We have reported that human large luteal cells in the ovarian corpus luteum of early pregnancy highly express human leukocyte antigen (HLA)-DR (Fujiwara et al., 1993) . HLA-DR is a ligand for CD4 antigen which is a specific marker for helper T-lymphocytes, and is considered to be a functional adhesion molecule for CD4 antigen-positive T-lymphocytes (Lanzavecchia, 1990) . We also found that leukocyte functional antigen-3, which is a ligand for a cell surface marker of Tlymphocytes, CD 2 antigen, is expressed on the cell surface of human luteal cells, and proposed that immune cells in early pregnancy identify the presence of embryos, transmit the information to the corpus luteum and regulate corpus luteum differentiation (Hattori et al., 1995) .
To extend this hypothesis, we previously examined the effect of immune cells prepared from mice in the early stages of pregnancy on embryo implantation. Intravenous administration of splenocytes obtained from early pregnancy was found to enhance implantation rates in female ICR mice undergoing embryo transfer on pseudopregnancy day 2. This effect was more pronounced with the splenocytes from pregnancy day 4 than those from pregnancy day 8, pseudopregnancy day 4 and dioestrous day 2 mice (Takabatake et al., 1997a) . Furthermore, it was shown that splenocytes from pregnant mice directly regulate endometrial differentiation and promote embryo implantation without affecting ovarian function, suggesting that an immunological approach may resolve implantation failure, which has been a focus of in-vitro fertilization and embryo transfer therapy (Takabatake et al., 1997b) .
It was also demonstrated that T-lymphocyte-rich cells derived from splenocytes facilitated implantation, but monocyte-rich cells did not. Therefore, in this study, to clarify the effect of T-lymphocytes on implantation, we further examined whether T-lymphocytes from non-pregnant mice could regulate endometrial differentiation and induce implantation by the use of thymocytes, most of which are T-lymphocytes, from immature female mice.
Materials and methods

Animals
Four week old female and 3 month old male ICR mice were purchased from Charles River Japan Inc. (Kanagawa, Japan). They were housed under controlled lighting (14 h of light, 10 h of darkness) and given water and food ad libitum.
Reagents
The animals were anaesthetized with nembutal (Dainabot Co., Osaka, Japan). Pregnant mare serum gonadotrophin (PMSG) and human chorionic gonadotrophin (HCG) were purchased from Teikoku Zoki Co. (Tokyo, Japan).
Thymocyte transfusion and embryo transfer in pseudopregnant mice
Thymocytes were obtained from 21 day old female mice. After killing by cervical dislocation, the thymus was carefully removed and placed on a Petri dish. The thymus was cut in several places and the pieces were pressed using scissors until primarily fibrous tissue remained. After filtration through nylon mesh, thymocytes were washed four times and suspended in phosphate buffered saline (PBS) at a concentration of 1ϫ10 8 cells/ml. Supernatant (Th-sup) obtained from the final suspension of thymocytes was also prepared. Blastocysts were recovered from donor pregnant ICR mice (pregnancy day 4), which were 5 weeks old and had been mated after stimulation with PMSG (5 IU) and HCG (5 IU). The 6 week old pseudopregnant recipient mice were prepared by mating with vasectomized males. At 1500 h on pseudopregnancy day 2, the recipient mice were injected with a 200 µl cell suspension of thymocytes or with 200 µl of Th-sup (control) through the caudal vein. Five embryos per uterus were transferred into each uterine cavity of recipient mice under anaesthesia by nembutal 1 h after the thymocyte transfusion. For each group, five recipients were used, and the experiments were repeated six times. Seven days after the embryo transfer, a laparotomy was performed, and embryo implantation was evaluated ( Figure 1A ).
Embryo transfer into ovariectomized pseudopregnant mice with supplementation of progesterone under thymocyte treatment
Thymocytes and blastocysts were prepared as described above. To induce and maintain delayed implantation, pseudopregnant ICR mice (6 weeks old) were ovariectomized in the afternoon of pseudopregnancy day 3 and given daily injections of progesterone (2 mg/mouse) from days 4-7 as described with minor modifications (Hogan et al., 1994; Dey, 1996; Takabatake et al., 1997b) . On pseudopregnancy days 7 and 8, the recipients were intravenously injected with thymocytes in PBS (2ϫ10 7 /200 µl) or Th-sup (200 µl) at 1500 h. The five blastocysts per uterus were transferred to the treated recipient mice at 1600 h on pseudopregnancy day 7. In each group, five recipients were used, and the experiments were repeated six times. The daily supplementation with progesterone was further continued and the implantation rate was evaluated 7 days after embryo transfer ( Figure 1B) .
To examine the effect of thymocytes on the expression of leukaemia inhibitory factor (LIF) mRNA, the oophorectomized pseudopregnant ICR mice treated by progesterone supplementation were killed 12 h or 24 h after a single injection of thymocytes or Th-sup, or subcutaneous injection with 17β-oestradiol (25 ng/body) on pseudopregnancy day 7, and the uteri were immediately removed and frozen in liquid nitrogen for reverse transcriptase-polymerase chain reaction (RT-PCR) analysis ( Figure 1C ).
RNA isolation
Total RNA of uterine tissues from the oophorectomized pseudopregnant mice in a delayed implantation model were isolated using the TRIzol method (Gibco BRL).
Isolation of murine LIF and β-actin cDNA clones Two micrograms of uterine total RNA from pregnant mice was reverse-transcribed with random primers using a commercial kit (First Strand cDNA Synthesis Kit ® ; Pharmacia Inc., Piscataway, NJ, USA). The resulting cDNA mixture was subjected to 30 cycles of PCR amplification with oligonucleotides from the murine LIF cDNA as primers (Gearing et al., 1988 ) (sense primer 5Ј-CCCATAATGAA-GGTCTTGGC-3Ј: position 10-29; antisense primer 5Ј-CTCCTCAC- TAGAATGCCTGGAC-3Ј: position 613-634) or with murine β-actin primers (Tokunaga et al., 1986 ) (sense primer 5Ј-TCAGAAGGAC-TCCTATGTGG-3Ј: position 224-243; antisense primer 5Ј-TCT-CTTTGATGTCACGCACG-3Ј: position 704-723). The PCR product, 625 bp in length, was cloned into a pBluescript SK(Ϫ) plasmid, and the insert was verified by sequencing (Higuchi et al., 1995) and used as a LIF probe for Southern blot analysis.
RT-PCR and Southern blot analysis
First-strand cDNA was prepared from 5 µg of total cellular RNA from each of the murine uterine samples as described above. PCR amplification of -µl cDNA with murine LIF primers was carried out as described above. A total of 16 µl from each PCR product was electrophoresed on 1% agarose gel and transferred to a nylon membrane (Hybond Nϩ ® ; Amersham, Arlington Heights, IL, USA). The membrane was hybridized with a [ 32 P]-labelled LIF probe as described by Church and Gilbert (1984) . The probe was labelled by random primer labelling (Megaprime ® ; Amersham) to a specific radioactivity of 0.8-1.5ϫ10 9 c.p.m./µg DNA. As a control for the amount of RNA loaded, each first strand cDNA mixture was also subjected to 25 cycles of PCR amplification with murine β-actin primers. PCR products were detected by ethidium-bromide staining on agarose gel electrophoresis.
Intra-endometrial administration of CD4(⍣/-)CD8(-) or CD4 (-)CD8(⍣/-) thymocytes and intraluminal embryo transfer into pseudopregnant mice
Pseudopregnant recipient mice, thymocytes and blastocysts were prepared as described above. Thymocytes were further divided into the CD4(ϩ/Ϫ)CD8(Ϫ) group and CD4(Ϫ)CD8(ϩ/Ϫ) group using separation columns, cellect-plus Mouse CD4 ® and CD8 ® kits (Biotex Lab. Inc., Alberta, Canada) according to the manufacturer's instructions. Briefly, thymocytes were applied to the activated cellectplus Mouse CD4 ® kit column, which separated CD4(ϩ/Ϫ)CD8(Ϫ) lymphocytes from CD8(ϩ) lymphocytes by negative selection. The cells that passed through the column were washed in PBS and then resuspended in PBS at a concentration of 1ϫ10 4 cells/µl. Similarly, thymocytes were applied to the activated cellect-plus Mouse CD8 ® kit column and CD4(Ϫ)CD8(ϩ/Ϫ) cells were resuspended in PBS (1ϫ10 4 cells/µl). The supernatants of each cell suspension were used as controls. The cell viability of separated cells was more than 90% by trypan blue exclusion. The separated cells in each group were stained with a mixture of fluorescein isothiocyanate (FITC)-conjugated-anti CD4 rat monoclonal antibody (mAb, IgG2a,κ, clone RM4-5; Pharmingen, San Diego, CA, USA) and R-phycoerythrin (R-PE)-conjugated-anti CD8 rat mAb (IgG2a,κ, clone 53-6.7; Pharmingen) or control mAbs (FITC-conjugated rat IgGa,κ and R-PEconjugated-rat IgGa,κ, Pharmingen). The subpopulations of the stained cells were analysed by flow cytometry (FACScan ® ; Becton Dickinson, Lincoln Park, NJ, USA).
At 1600 h on pseudopregnancy day 2, 1 µl of CD4(ϩ/Ϫ)CD8(Ϫ) or CD4(Ϫ)CD8(ϩ/Ϫ) lymphocytes suspended in PBS (1ϫ10 4 cells/ µl) was gently injected into the unilateral endometrial stroma along the uterine long axis using a fine micropipette after parallel insertion of a 27 g injection needle as described previously (Goto et al., 1992; Nakayama et al., 1995) . The supernatants of each cell suspension (1 µl) were injected into the contralateral endometrial stroma as a control. Immediately after the intra-endometrial injection, five embryos per uterus were transferred into each luminal cavity of the uteri.
In each experiment, five recipients were used, and the experiments were repeated six times. The implantation sites were evaluated 7 days after embryo transfer ( Figure 1D ).
Statistical analysis
Implantation rates per recipient or embryo (%) were calculated in each experiment and expressed as means ϮSD. The differences in implantation rates between the thymocyte-or supernatant-treated groups were analysed by the two-tailed paired t-test. The difference was considered to be significant at P Ͻ 0.05.
Results
Implantation rates in pseudopregnant mice with intravenous administration of thymocytes Implantation rates in pseudopregnant mice, transferred with blastocysts on pseudopregnancy day 2, were significantly higher in the thymocyte-treated group than in the Th-suptreated group (P Ͻ 0.01) (Figure 2 ).
The effect of thymocyte administration on embryo transfer in ovariectomized pseudopregnant mice
In pseudopregnant ICR mice, which were oophorectomized on pseudopregnancy day 3 and followed by progesterone supplementation, blastocysts were transferred into the uterine cavities with intravenous injection of thymocytes or Th-sup. Seven days after embryo transfer, successful implantation was observed in the thymocyte-treated group, but no implantation was observed in the Th-sup-treated group (P Ͻ 0.01) (Figure 3) .
RT-PCR analysis of LIF mRNA expression in the uterus
In the mice that underwent experimental delay of implantation, the injection of 17β-oestradiol or thymocytes induced distinct expression of LIF mRNA 12 and 24 h after injection. Sensitive RT-PCR Southern blotting could not detect LIF mRNA expression when Th-sup was injected (Figure 4) .
Implantation rates in pseudopregnant mice with intra-endometrial administration of CD4(-)CD8(⍣/-) or CD4(⍣/-)CD8 (-) lymphocytes
Flow cytometry analysis confirmed that the rates of contamination of CD4-positive and CD8-positive cells were less than 4 and 7% in the CD4(Ϫ)CD8(ϩ/Ϫ) and CD4(ϩ/Ϫ)CD8(Ϫ) cell preparations, respectively ( Figure 5 ).
In pseudopregnancy day 2 mice, which received unilateral Figure 4 . Effects of systemically administered thymocytes or 17β-oestradiol on LIF mRNA expression in uteri of delayed implantation mice. Experimentally induced delay of implantation was achieved as described in Materials and methods, and 17β-oestradiol, or thymocytes in PBS, or Th-sup (sup) were systemically administered on day 7 of pseudopregnancy. Whole uteri from these mice were collected 12 h and 24 h after administration, and first strand cDNA from these samples were subjected to RT-PCR amplification with LIF primers. Southern blot analysis of PCR products hybridized with a LIF probe (upper panel). Control PCR using β-actin specific primers was detected by ethidium-bromide staining (lower panel). Expression of uterine LIF mRNA was evident with 17β-oestradiol (E 2 ) or thymocyte (Thy) administration. intra-endometrial injection with CD4(Ϫ)CD8(ϩ/Ϫ) or CD4 (ϩ/Ϫ)CD8(Ϫ) lymphocytes and intraluminal embryo transfer, the implantation rates per embryo were significantly higher in the CD4(ϩ/Ϫ)CD8(Ϫ) group (21.1 Ϯ 16.4%) than in the control group (4.7 Ϯ 8.8%, P Ͻ 0.01) (Figure 6 ). In contrast, no significant difference in implantation rate per embryo was observed in the CD4(Ϫ)CD8(ϩ/Ϫ) group compared with the control group (9.6 Ϯ 9.2% versus 4.1 Ϯ 6.3%) (Figure 6 ).
Discussion
Successful embryo implantation requires the synchronization of embryo development and uterine preparation (Beier et al., 1970 (Beier et al., , 1989 . In rodents, the uterus is in the receptive phase for only a few days, the so-called 'implantation window' (Psychoyos, 1993; Dey, 1996) . In general, the ovarian steroid hormones are considered to play a major role in creating a limited phase of endometrial receptivity (Finn, 1966; Finn and Martin, 1970; Psychoyos, 1973 Psychoyos, , 1993 Dey, 1996) . The endometrium is also immunologically interesting, because the semi-allogeneic embryo/fetus is normally not rejected by the mother. Endometrial stromal cells and endometrial lymphocytes constitute the maternal aspect of the maternofetal interface, and are considered to contribute to successful pregnancy (Kearns and Lala, 1983; Bulmer, 1996) . It has been reported that the endometrium contains many cytokines (Tabibzadeh, 1991) , and some of these cytokines have been demonstrated to be related to endometrial differentiation and blastocyst implantation in an autocrine and/or paracrine fashion (Kariya et al., 1991; Irwin et al., 1991; Simón et al., 1996) . Recently, implantation failure has been a focus of in-vitro fertilization and embryo transfer therapy, in which embryos of good quality fail in successful implantation. Abnormal endometrial differentiation and/or immune responses are considered to cause implantation failure (Edwards, 1995) , and few effective therapies have been proposed for patients who do not respond to steroid hormone stimulation.
Previously, we demonstrated that systemic administration of splenocytes from ICR mice in the early stages of pregnancy promoted the receptivity of the uterus on pseudopregnant day 2 (Takabatake et al., 1997a) . In ICR mice, splenocytes derived from pregnancy day 4 mice more effectively facilitated embryo implantation than splenocytes derived from pregnancy day 8, pseudopregnancy day 4 and dioestrous day 2 mice, suggesting that the presence of an embryo in the donor mice for splenocyte preparation is important for the effect of splenocytes on implantation (Takabatake et al., 1997a) . To exclude the possibility that non-specific immune reaction to allograft is involved in the effect of spleen cell transfusion, we confirmed the similar effect of splenocytes in early pregnancy on embryo implantation using BALB/c mice, which is an inbred strain (Takabatake et al., 1997b) . Furthermore, intra-endometrial injection of splenocytes prepared from mice in the early stages of pregnancy also enhanced embryo implantation and this effect was greater in the T-lymphocyte-rich preparation (Takabatake et al., 1997b) . Therefore, we proposed that intra-endometrial injection of lymphocytes may be one possible clinical approach in the therapy for implantation failure.
For the clinical application of this procedure, autologous lymphocytes should be used in the local injection. To this end, peripheral blood lymphocytes obtained from non-pregnant infertile patients may be used after some treatment to make lymphocytes mimicking those of early pregnancy. Therefore, we first examined whether non-pregnant lymphocytes have any effect on embryo implantation or not. In this study, it was shown that intravenous administration of thymocytes derived from immature non-pregnant female mice significantly pro- Figure 6 . Implantation rates in the pseudopregnant mice with intraendometrial administration of CD4(Ϫ)CD8(ϩ/Ϫ) or CD4(ϩ/Ϫ)CD8(Ϫ) lymphocytes. The significantly higher implantation rate per embryo was observed in the CD4(ϩ/ Ϫ)CD8(Ϫ) cell group, whereas it was not significantly different (n.s.) in the CD4(Ϫ)CD8(ϩ/Ϫ) cell group (*P Ͻ 0.01). Values are means ϮSD.
2892 moted embryo implantation in recipient mice on pseudopregnancy day 2, providing evidence that non-pregnant Tlymphocytes may be used as adjuvant therapy for implantation failure. The above result is compatible with the previous observation that splenocytes derived from non-pregnant mice tended to facilitate embryo implantation, although this tendency was not significant (Takabatake et al., 1997a) . The estimated number of mature T-lymphocytes in the thymocyte preparation in the present study is similar to or rather smaller than that of splenocyte preparation in the previous study. However, the effect of thymocytes from non-pregnant mice was apparently higher than that of splenocytes from non-pregnant mice, whereas it was as high as that of splenocytes from pregnant mice. The possible explanation for the different effects observed in the thymocyte and splenocyte preparations from non-pregnant mice is that the specific population of T-lymphocytes, which is rich in the thymocytes, plays an important role in endometrial receptivity. These T-lymphocytes may be mobilized to the peripheral circulation and be activated by undefined embryonal signals to facilitate embryo implantation during early pregnancy.
Using a delayed implantation model, we examined whether the effects of thymocytes are converted via regulation of ovarian function or not. In oophorectomized pseudopregnant mice, progesterone supplementation reportedly cannot induce embryo implantation without oestrogen administration (Yoshinaga and Adams, 1966) . We previously confirmed that oestrogen administration induced embryo implantation and that successful implantation was not observed without oestrogen administration using the same delayed implantation model as this report (Takabatake et al., 1997b) . It was also demonstrated that intravenous administration of splenocytes derived from early pregnancy could induce embryo implantation, indicating that the ovary is not necessarily essential for the promotional effect of splenocytes on implantation (Takabatake et al., 1997b) . In this study, intravenous administration of thymocytes induced embryo implantation in oophorectomized pseudopregnant mice. Taken together with the previous results of intra-endometrial splenocyte injection, we speculated that T-lymphocytes directly affect the endometrium to enhance embryo implantation.
We further examined the effect of thymocytes on endometrial differentiation by detecting the expression of LIF mRNA in the uterus of oophorectomized pseudopregnant mice under progesterone supplementation. LIF is reported to be indispensable for implantation in mice (Stewart et al., 1992) , and to be induced in the uterus with oestradiol administration in the delayed implantation model (Bhatt et al., 1991) . We previously confirmed the induction of LIF mRNA expression by oestradiol and by intravenous administration of splenocytes derived from early pregnancy using the same delayed implantation model, showing that endometrial differentiation and embryo implantation are regulated under dual control by the endocrine and immune systems (Takabatake et al., 1997b) . Under these conditions, similar induction of LIF mRNA in the uterus was observed by thymocyte administration. This suggests that thymocytes can regulate endometrial differentiation to support embryo implantation without oestrogen stimulation.
It is reported that a variety of immune cells, such as granulated lymphocyte-like cells and macrophages, are present in the endometrium and that their population changes in accordance with the oestrus cycle and pregnancy (Peel and Bulmer, 1977; Bulmer and Sunderland, 1984; Stewart, 1984; Parr et al., 1990; De et al., 1991; Bulmer, 1996) . Recently, immunotrophism for embryo implantation was proposed by Wegmann et al. (reviewed by Dudley, 1996) . They speculated that the maternal immune state which is most beneficial to reproductive fitness is maintained by the local secretion of Th2 cytokines, particularly IL-10 (Wegmann, 1993; Chaouat et al., 1995) . In this study, intra-endometrial administration of CD4(ϩ/Ϫ)CD8(Ϫ) cells from thymocytes enhanced embryo implantation. Although this preparation contains CD4(Ϫ)CD8 (Ϫ) cells, such as NK cells, the main effective cells may be CD4(ϩ)CD8(Ϫ) cells since CD4(Ϫ)CD8(ϩ/Ϫ) cells, which also contain CD4(Ϫ)CD8(Ϫ) cells, showed no significant effect on implantation. While CD4(ϩ) lymphocytes are composed of both Th1 and Th2 lymphocytes, the stimulatory effect of CD4(ϩ)CD8(Ϫ) cells on embryo implantation is compatible with the immunotrophism theory of Wegmann et al. (1993) . This effect of lymphocytes can perhaps be augmented by adequate in-vitro treatment in the future. If so, intra-endometrial injection of pretreated autologous peripheral lymphocytes may provide an effective immunological approach to therapy in cases of implantation failure.
In conclusion, we demonstrated that thymocytes derived from immature female mice promote murine embryo implantation, probably by regulating endometrial differentiation. This effect of thymocytes is suggested to be caused primarily by CD4-positive lymphocytes. Further clarification of these mechanisms will contribute to therapy for implantation failure.
